Cargando…

Tauopathic Changes in the Striatum of A53T α-Synuclein Mutant Mouse Model of Parkinson's Disease

Tauopathic pathways lead to degenerative changes in Alzheimer's disease and there is evidence that they are also involved in the neurodegenerative pathology of Parkinson's disease [PD]. We have examined tauopathic changes in striatum of the α-synuclein (α-Syn) A53T mutant mouse. Elevated l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wills, Jonathan, Credle, Joel, Haggerty, Thomas, Lee, Jae-Hoon, Oaks, Adam W., Sidhu, Anita
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3061878/ https://www.ncbi.nlm.nih.gov/pubmed/21445308 http://dx.doi.org/10.1371/journal.pone.0017953

Ejemplares similares

Region-specific tauopathy and synucleinopathy in brain of the alpha-synuclein overexpressing mouse model of Parkinson's disease
por: Kaul, Tiffany, et al.
Publicado: (2011)

Synucleins Antagonize Endoplasmic Reticulum Function to Modulate Dopamine Transporter Trafficking
por: Oaks, Adam W., et al.
Publicado: (2013)

Correction: Paraquat, but Not Maneb, Induces Synucleinopathy and Tauopathy in Striata of Mice through Inhibition of Proteasomal and Autophagic Pathways
por: Wills, Jonathan, et al.
Publicado: (2012)

Paraquat, but Not Maneb, Induces Synucleinopathy and Tauopathy in Striata of Mice through Inhibition of Proteasomal and Autophagic Pathways
por: Wills, Jonathan, et al.
Publicado: (2012)

Developmental Changes in Dendritic Spine Morphology in the Striatum and Their Alteration in an A53T α-Synuclein Transgenic Mouse Model of Parkinson’s Disease
por: Parajuli, Laxmi Kumar, et al.
Publicado: (2020)

Age-Dependent Effects of A53T Alpha-Synuclein on Behavior and Dopaminergic Function
por: Oaks, Adam W., et al.
Publicado: (2013)

Identification of the Sites of Tau Hyperphosphorylation and Activation of Tau Kinases in Synucleinopathies and Alzheimer’s Diseases
por: Duka, Valeriy, et al.
Publicado: (2013)

The Significance of Asymmetry in the Assessment of Brain Perfusion in Atypical Tauopathic Parkinsonian Syndromes
por: Alster, Piotr, et al.
Publicado: (2022)

Parallel mechanisms for direct and indirect membrane protein trafficking by synucleins
por: Oaks, Adam W, et al.
Publicado: (2013)

Small Heat Shock Protein 22 Improves Cognition and Learning in the Tauopathic Brain
por: Rodriguez Ospina, Santiago, et al.
Publicado: (2022)

Neurodegeneration and contralateral α-synuclein induction after intracerebral α-synuclein injections in the anterior olfactory nucleus of a Parkinson’s disease A53T mouse model
por: Flores-Cuadrado, Alicia, et al.
Publicado: (2019)

Ncx3-Induced Mitochondrial Dysfunction in Midbrain Leads to Neuroinflammation in Striatum of A53t-α-Synuclein Transgenic Old Mice
por: Di Martino, Rossana, et al.
Publicado: (2021)

Silencing of Glucocerebrosidase Gene in Drosophila Enhances the Aggregation of Parkinson's Disease Associated α-Synuclein Mutant A53T and Affects Locomotor Activity
por: Abul Khair, Salema B., et al.
Publicado: (2018)

Macroautophagy in sporadic and the genetic form of Parkinson's disease with the A53T α-synuclein mutation
por: Huang, Yue, et al.
Publicado: (2012)

Intracellular A53T Mutant α-Synuclein Impairs Adult Hippocampal Newborn Neuron Integration
por: Regensburger, Martin, et al.
Publicado: (2020)

Poly (ADP‐ribose) polymerase 1 inhibition prevents neurodegeneration and promotes α‐synuclein degradation via transcription factor EB‐dependent autophagy in mutant α‐synucleinA53T model of Parkinson's disease
por: Mao, Kanmin, et al.
Publicado: (2020)

Absence of α-synuclein affects dopamine metabolism and synaptic markers in the striatum of aging mice()
por: Al-Wandi, Abdelmojib, et al.
Publicado: (2010)

Pronounced α-Synuclein Pathology in a Seeding-Based Mouse Model Is Not Sufficient to Induce Mitochondrial Respiration Deficits in the Striatum and Amygdala
por: Burtscher, Johannes, et al.
Publicado: (2020)

Oral Exposure to Paraquat Triggers Earlier Expression of Phosphorylated α-Synuclein in the Enteric Nervous System of A53T Mutant Human α-Synuclein Transgenic Mice
por: Naudet, Nicolas, et al.
Publicado: (2017)

Astrocytic expression of Parkinson's disease-related A53T α-synuclein causes neurodegeneration in mice
por: Gu, Xing-Long, et al.
Publicado: (2010)

Longitudinal Metabolomics Profiling of Parkinson’s Disease-Related α-Synuclein A53T Transgenic Mice
por: Chen, Xi, et al.
Publicado: (2015)

Proteasome inhibitor-induced autophagy in PC12 cells overexpressing A53T mutant α-synuclein
por: LAN, DANMEI, et al.
Publicado: (2015)

Trehalose Inhibits A53T Mutant α-Synuclein Overexpression and Neurotoxicity in Transduced PC12 Cells
por: Zhao, Juan, et al.
Publicado: (2017)

α-Synuclein inclusions in the skin of Parkinson's disease and parkinsonism
por: Rodríguez-Leyva, Ildefonso, et al.
Publicado: (2014)

Environmental Enrichment Attenuates Oxidative Stress and Alters Detoxifying Enzymes in an A53T α-Synuclein Transgenic Mouse Model of Parkinson’s Disease
por: Seo, Jung Hwa, et al.
Publicado: (2020)

A53T-α-synuclein overexpression in murine locus coeruleus induces Parkinson’s disease-like pathology in neurons and glia
por: Henrich, Martin Timo, et al.
Publicado: (2018)

α-Synuclein Trafficking in Parkinson’s Disease: Insights From Fly and Mouse Models
por: Cheng, Jingjing, et al.
Publicado: (2018)

Phosphorylation of Parkin at serine 131 by p38 MAPK promotes mitochondrial dysfunction and neuronal death in mutant A53T α-synuclein model of Parkinson’s disease
por: Chen, Jialong, et al.
Publicado: (2018)

Mitochondrial division inhibitor-1 is neuroprotective in the A53T-α-synuclein rat model of Parkinson’s disease
por: Bido, Simone, et al.
Publicado: (2017)

Pre-Fibrillar α-Synuclein Mutants Cause Parkinson's Disease-Like Non-Motor Symptoms in Drosophila
por: Gajula Balija, Madhu Babu, et al.
Publicado: (2011)

Neuroprotective effects of genistein on SH-SY5Y cells overexpressing A53T mutant α-synuclein
por: Wu, Huan-Cheng, et al.
Publicado: (2018)

Anti-α-synuclein ASO delivered to monoamine neurons prevents α-synuclein accumulation in a Parkinson's disease-like mouse model and in monkeys
por: Alarcón-Arís, Diana, et al.
Publicado: (2020)

Therapeutic functions of astrocytes to treat α-synuclein pathology in Parkinson’s disease
por: Yang, Yunseon, et al.
Publicado: (2022)

Salivary total α-synuclein, oligomeric α-synuclein and SNCA variants in Parkinson’s disease patients
por: Kang, Wenyan, et al.
Publicado: (2016)

Functionally different α-synuclein inclusions yield insight into Parkinson’s disease pathology
por: Raiss, Christian C., et al.
Publicado: (2016)

α - synuclein and Parkinson’s disease: the first roadblock
por: Lin Chua, Christelle En, et al.
Publicado: (2006)

Immunological features of α-synuclein in Parkinson's disease
por: Roodveldt, Cintia, et al.
Publicado: (2008)

Models of α-synuclein aggregation in Parkinson’s disease
por: Giráldez-Pérez, Rosa María, et al.
Publicado: (2014)

Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
por: Emamzadeh, Fatemeh Nouri
Publicado: (2017)

The Role of α-Synuclein Oligomers in Parkinson’s Disease
por: Du, Xiao-yu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ghi2j46gb67bnbf62ov7gl5nug